|
|
|
|
|
| Terms & Properties |
Concept Unique Identifier (CUI): C0065864
NCI Thesaurus Code: C1155 (see NCI Thesaurus info)
Semantic Type: Hormone
Semantic Type: Pharmacologic Substance
NCIt Definition: A synthetic, acetate derivative of the sex hormone progesterone. Medroxyprogesterone 17-acetate (NCI04)
NCI-GLOSS Definition: A drug used to prevent endometrial cancer. It is also used to treat menstrual disorders and as a form of birth control. It is a form of the female hormone progesterone and belongs to the family of drugs called progestins.
MSH Definition: A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Synonyms & Abbreviations: (see Synonym Details)
| (6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione |
| (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione |
| (6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione |
| 17-(Acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione |
| 17-Acetoxy-6alpha-methylprogesterone |
| 17-Acetoxy-6α-methylprogesterone |
| 17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione Acetate |
| 17Alpha-acetoxy-6alpha-methylprogesterone |
| 17alpha-Hydroxy-6alpha-methylprogesterone acetate |
| 17α-hydroxy-6α-methylprogesterone acetate |
| 6 alpha Methyl 17alpha hydroxyprogesterone Acetate |
| 6-alpha-Methyl-17-alpha-acetoxyprogesterone |
| 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate |
| 6-Alpha-methyl-17alpha-acetoxyprogesterone |
| 6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate |
| 6alpha-Methyl-17-acetoxy progesterone |
| 6alpha-Methyl-17alpha-hydroxyprogesterone acetate |
| 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate |
| 6α-Methyl-17-acetoxy progesterone |
| 6α-Methyl-17α-hydroxyprogesterone acetate |
| Amen |
| Aragest |
| Ciclotal |
| Clinofem |
| Clinovir |
| Cycrin |
| Depo Medroxyprogesterone Acetate |
| Depo Provera |
| Depo-Clinovir |
| Depo-Medroxyprogesterone Acetate |
| Depo-provera |
| DepoProvera |
| Depot-Medroxyprogestereone Acetate |
| Farlutal |
| G-Farlutal |
| Gestapuran |
| Hysron |
| Lutoral |
| Medroxyacetate progesterone |
| Medroxyprogesterone 17 Acetate |
| Medroxyprogesterone 17-acetate |
| Medroxyprogesterone acetate (substance) |
| MEDROXYPROGESTERONE ACETATE 17 |
| Medroxyprogesterone Acetate [Chemical/Ingredient] |
| Medroxyprogesterone acetate preparation |
| Medroxyprogesterone Acetate |
| Medroxyprogesteroni Acetas |
| Methylacetoxyprogesterone |
| Metigestrona |
| Metipregnone |
| MPA |
| Nadigest (vet) |
| Nadigest |
| Nidaxin (vet) |
| Nidaxin |
| Oragest |
| Perlutex |
| Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)- |
| Prodasone |
| Product containing medroxyprogesterone acetate (medicinal product) |
| Product containing medroxyprogesterone acetate |
| Provera |
| Sodelut G |
| Veramix |
External Source Codes:
| NCI Thesaurus Code | C1155 (see NCI Thesaurus info) |
| CAS Registry Number | 71-58-9 (see NLM ChemIDplus info) |
| FDA UNII Code | C2QI4IOI2G |
| NSC Code | 21171 (see NCI DTP info) |
| NSC Code | 26386 (see NCI DTP info) |
Other Properties:
| Name | Value | Source |
|---|---|---|
| ACTIVE | 1 | SNOMEDCT_US |
| AQL | AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR | MSH |
| CASE_SIGNIFICANCE_ID | 900000000000448009 | SNOMEDCT_US |
| CHARACTERISTIC_TYPE_ID | 900000000000011006 | SNOMEDCT_US |
| CHEBI_ID | CHEBI:6716 | NCI |
| Chemical_Formula | C24H34O4 | NCI |
| Contributing_Source | CTRP | NCI |
| Contributing_Source | FDA | NCI |
| CTV3ID | XU6ek | SNOMEDCT_US |
| CTV3ID | XUApz | SNOMEDCT_US |
| DC | 1 | MSH |
| DEFINITION_STATUS_ID | 900000000000074008 | SNOMEDCT_US |
| DID | 2422-8564 | CSP |
| DX | 19930101 | MSH |
| EFFECTIVE_TIME | 20020131 | SNOMEDCT_US |
| FDA_UNII_CODE | C2QI4IOI2G | DRUGBANK |
| FDA_UNII_CODE | C2QI4IOI2G | NDFRT |
| HN | 2010 (1973) | MSH |
| LEVEL | Ingredient | NDFRT |
| LEVEL | Salts/Esters | USPMG |
| LT | TRD | MSH |
| LT | TRD | MTH |
| MDA | 19920518 | MSH |
| MESH_DEFINITION | A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms. | NDFRT |
| MESH_DUI | D017258 | NDFRT |
| MESH_NAME | Medroxyprogesterone Acetate | NDFRT |
| MESH_UI | M0026185 | NDFRT |
| MMR | 20160531 | MSH |
| MN | D04.210.500.745.745.654.829.395.700.500 | MSH |
| MODIFIER_ID | 900000000000451002 | SNOMEDCT_US |
| NDFRT_KIND | DRUG_KIND | NDFRT |
| NDFRT_KIND | INGREDIENT_KIND | NDFRT |
| NUI | N0000007209 | NDFRT |
| NUI | N0000146186 | NDFRT |
| PA | D003271 | MSH |
| PA | D003272 | MSH |
| PA | D018931 | MSH |
| PM | 2010; see MEDROXYPROGESTERONE 17-ACETATE 1993-2009; MEDROXYPROGESTERONE 17-ACETATE was indexed under MEDROXYPROGESTERONE/analogs & derivatives 1978-1992, HYDROXYPROGESTERONES 1976-78, & MEDROXYPROGESTERONE 1973-75 | MSH |
| RN | 0 | MSH |
| RN | C2QI4IOI2G | MSH |
| RR | 1172-82-3 (cpd w/o isomeric designation) | MSH |
| RR | 2242-65-1 ((6 beta)-isomer) | MSH |
| RR | 560-12-3 ((6 alpha,17 alpha)-isomer) | MSH |
| RR | 71-58-9 (Medroxyprogesterone Acetate) | MSH |
| RXAUI | 1136878 | RXNORM |
| RXAUI | 1136888 | RXNORM |
| RXAUI | 1136892 | RXNORM |
| RXAUI | 1136901 | RXNORM |
| RXAUI | 2072205 | RXNORM |
| RXAUI | 2599730 | RXNORM |
| RXAUI | 2772933 | RXNORM |
| RXAUI | 3090882 | RXNORM |
| RXAUI | 3094465 | RXNORM |
| RXAUI | 3145780 | RXNORM |
| RXAUI | 3192009 | RXNORM |
| RXAUI | 3192010 | RXNORM |
| RXAUI | 3197082 | RXNORM |
| RXAUI | 3197083 | RXNORM |
| RXAUI | 3197085 | RXNORM |
| RXAUI | 3223235 | RXNORM |
| RXAUI | 3281929 | RXNORM |
| RXAUI | 3733572 | RXNORM |
| RXAUI | 710139 | RXNORM |
| RXCUI | 1000112 | RXNORM |
| RXCUI | 202886 | RXNORM |
| RXCUI | 202887 | RXNORM |
| RXCUI | 202888 | RXNORM |
| RXCUI | 202891 | RXNORM |
| RXCUI | 91770 | RXNORM |
| RXN_ACTIVATED | 01/28/2010 | RXNORM |
| RXN_ACTIVATED | 06/01/2016 | RXNORM |
| RXN_BN_CARDINALITY | single | RXNORM |
| RXN_OBSOLETED | 03/27/2013 | RXNORM |
| RXN_OBSOLETED | 06/28/2016 | RXNORM |
| RXN_OBSOLETED | 08/30/2007 | RXNORM |
| SID | APRD00627 | DRUGBANK |
| SPL_SET_ID | 04d23262-b778-4815-b56f-6ca6fef826c0 | MTHSPL |
| SPL_SET_ID | 0930a471-6ff1-43a1-b3ea-948ca3f99d06 | MTHSPL |
| SPL_SET_ID | 0ceb4952-5af3-4b80-b8b5-cea4e9a5486d | MTHSPL |
| SPL_SET_ID | 198d547d-c985-46bc-a66f-e3182a294cb5 | MTHSPL |
| SPL_SET_ID | 199cf13e-0859-4a73-9b45-e700d0cd1049 | MTHSPL |
| SPL_SET_ID | 20c0841f-740c-4d53-af55-938c4e5b09e5 | MTHSPL |
| SPL_SET_ID | 210a9132-8837-4b8a-829c-abfac2d6e3dc | MTHSPL |
| SPL_SET_ID | 2425f944-15d7-4b84-95a0-6538e843f130 | MTHSPL |
| SPL_SET_ID | 2627eb11-06bf-4a45-9172-094468e3ca07 | MTHSPL |
| SPL_SET_ID | 36ec4df9-298d-4b15-9386-7848d217a46c | MTHSPL |
| SPL_SET_ID | 37275fd0-eb24-40a4-a93f-b818bb98414e | MTHSPL |
| SPL_SET_ID | 390087a6-f3c3-4f0b-a930-79acf412f153 | MTHSPL |
| SPL_SET_ID | 428481bb-b7cf-4d76-b57d-0d6bfa2b6ac3 | MTHSPL |
| SPL_SET_ID | 437edd12-2c08-4df4-8cf7-64c47e4779ac | MTHSPL |
| SPL_SET_ID | 468a972c-cb14-47c3-bdf6-4f7b64509e5c | MTHSPL |
| SPL_SET_ID | 499051ac-ffaf-4db4-be45-a409bd54991f | MTHSPL |
| SPL_SET_ID | 51588bf9-ad2f-42d5-83a7-3431b6e891e3 | MTHSPL |
| SPL_SET_ID | 519f68cd-0751-4117-971b-f928dccdf5ba | MTHSPL |
| SPL_SET_ID | 571982db-e1ce-4c64-98c3-86f66f3e77b9 | MTHSPL |
| SPL_SET_ID | 67f65a9d-26d7-4b37-bff6-0caf3904dffd | MTHSPL |
| SPL_SET_ID | 701acf2c-fffe-451a-9b94-82d825e5a47c | MTHSPL |
| SPL_SET_ID | 788df737-e990-4b5e-accd-af13c3b2bf8b | MTHSPL |
| SPL_SET_ID | 816b9fd2-bc55-496b-846a-cabe7bbdecd6 | MTHSPL |
| SPL_SET_ID | 826f674c-8ef2-400a-bf0b-877320a8cb5d | MTHSPL |
| SPL_SET_ID | 8691e529-0681-47f4-bab8-c6873f1e1424 | MTHSPL |
| SPL_SET_ID | 8ad58c4b-c263-4562-92cd-b1f81f3e06b3 | MTHSPL |
| SPL_SET_ID | 91b3473d-b95b-4b7d-a1d4-3ff2cb75a9b9 | MTHSPL |
| SPL_SET_ID | 93b7c9e8-fa4a-4b6f-879f-d71fd251e349 | MTHSPL |
| SPL_SET_ID | 9eb200b0-db96-4a51-87ea-04db862978c8 | MTHSPL |
| SPL_SET_ID | a586be28-96af-4fed-a13f-9b94fd4c7405 | MTHSPL |
| SPL_SET_ID | b1a02aba-b398-46c4-b98b-7064797aaa4b | MTHSPL |
| SPL_SET_ID | b2573b85-a1d6-4ed8-a026-70ce8ed22ee1 | MTHSPL |
| SPL_SET_ID | b840f2b0-4c37-40f3-9c1c-cd906e3e1c5e | MTHSPL |
| SPL_SET_ID | bc417aba-2b32-4943-9031-ff2bf79c2dcb | MTHSPL |
| SPL_SET_ID | bdb89690-ced2-48e1-bb1a-e5eccfeda8eb | MTHSPL |
| SPL_SET_ID | bfdf335d-1cbb-4533-9fde-99a9c71f7504 | MTHSPL |
| SPL_SET_ID | c91f0af4-1411-4ab6-8b3c-b8dcfa56a9b7 | MTHSPL |
| SPL_SET_ID | cbf142f9-9af3-4d79-9343-0ab42d6dbe9f | MTHSPL |
| SPL_SET_ID | cd0bbdb2-754e-4e66-8f36-985b5819d642 | MTHSPL |
| SPL_SET_ID | cebb0059-0811-4289-8586-4e416ffed1ae | MTHSPL |
| SPL_SET_ID | d279981c-e9e4-4989-bafb-1e184a6d3dd2 | MTHSPL |
| SPL_SET_ID | d2c3d585-3b01-448b-a630-3ea9aa34bccb | MTHSPL |
| SPL_SET_ID | e1d5975a-e0e5-444d-bab0-3904c3f377c9 | MTHSPL |
| SPL_SET_ID | e5f5c46c-b8b7-4502-9d2b-8f12284d1a63 | MTHSPL |
| SPL_SET_ID | ec517411-6d3d-4cb1-a50e-f0818d03b0e4 | MTHSPL |
| SPL_SET_ID | fd0c0836-5d23-2183-da81-9dc7f4287052 | MTHSPL |
| SPL_SET_ID | fda3368b-4ce3-4972-885d-066858831ee0 | MTHSPL |
| SUBSET_MEMBER | 900000000000497000~MAPTARGET~XU6ek | SNOMEDCT_US |
| SUBSET_MEMBER | 900000000000497000~MAPTARGET~XUApz | SNOMEDCT_US |
| SUBSET_MEMBER | 900000000000508004~ACCEPTABILITYID~900000000000548007 | SNOMEDCT_US |
| SUBSET_MEMBER | 900000000000508004~ACCEPTABILITYID~900000000000549004 | SNOMEDCT_US |
| SUBSET_MEMBER | 900000000000509007~ACCEPTABILITYID~900000000000548007 | SNOMEDCT_US |
| SUBSET_MEMBER | 900000000000509007~ACCEPTABILITYID~900000000000549004 | SNOMEDCT_US |
| TERMUI | T051457 | MSH |
| TERMUI | T051458 | MSH |
| TERMUI | T051459 | MSH |
| TERMUI | T051460 | MSH |
| TERMUI | T051461 | MSH |
| TERMUI | T051462 | MSH |
| TERMUI | T051463 | MSH |
| TERMUI | T051464 | MSH |
| TERMUI | T051467 | MSH |
| TERMUI | T051468 | MSH |
| TERMUI | T051469 | MSH |
| TERMUI | T051470 | MSH |
| TH | FDA SRS (2014) | MSH |
| TH | NLM (1993) | MSH |
| TH | NLM (1998) | MSH |
| TH | POPLINE (1978) | MSH |
| TH | USP (19XX) | MSH |
| TYPE_ID | 900000000000003001 | SNOMEDCT_US |
| TYPE_ID | 900000000000013009 | SNOMEDCT_US |
| VANDF_RECORD | 50.416^423^Active/Master | NDFRT |
| VUID | 4017828 | NDFRT |
Additional Concept Data: (none)
URL to Bookmark: https://ncim-stage.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&code=C0065864
